Homepage
Latest Videos
Latest Videos
Brightcove Home Latest Listing
Breast Cancer
Breast Cancer
Brightcove Cards Listing
Prostate Cancer
Brightcove Cards Listing
Multiple Myeloma
Multiple Myeloma
Brightcove Cards Listing
Popular on MedEnrich
Popular in No name
Multiple Myeloma8m 41s
Managing Side Effects of Immunotherapies in Multiple Myeloma
Management strategies include steroids, tocilizumab, antimicrobial prophylaxis, and multidisciplinary collaboration. Early recognition and tailored interventions are crucial for improving patient outcomes. For a deeper understanding check this video.
crs
neurotoxicity
immunotherapies
myeloma
1

Managing Side Effects of Immunotherapies in...
Multiple Myeloma9m 52s
Guidelines for using Bispecific Antibodies in Multiple Myeloma
Bispecific antibodies, particularly T-cell-engaging ones, are emerging as effective therapies for relapsed/refractory multiple myeloma. Prophylactic measures and tailored dosing strategies are crucial for minimizing adverse effects.
bispecific antibodies
multiple myeloma
cytokine release syndrome
immunotherapy
1

Guidelines for using Bispecific Antibodies in...
Myelodysplastic Syndromes11m 58s
Optimizing Treatment of Frontline AML - Review of Clinical Evidence
Optimizing frontline AML treatment involves integrating molecular diagnostics, risk stratification, and targeted therapies to personalize care.
frontline aml treatment
targeted therapies
personalized care
risk stratification
1

Optimizing Treatment of Frontline AML - Review of...
OncoSpecials50m 57s
Understanding Biosimilars -An Expert Perspective
Biosimilars are biologic medicines that are highly similar to an FDA-approved reference product, with no clinically meaningful differences in terms of safety, purity, and potency.
biosimilar
biologics
expert perspective
1

Understanding Biosimilars -An Expert Perspective
Myelodysplastic Syndromes2m 50s
Maintenance Midostaurin -There Not There
Maintenance therapy with Midostaurin in AML patients with FLT3 mutations has shown potential in improving event-free survival and reducing relapse risk.
maintenance therapy
midostaurin
flt3 mutations
1

Maintenance Midostaurin -There Not There
Multiple Myeloma7m 7s
VRD vs VCD Regimen in Real World Clinical Practice
In real-world clinical practice, the VRD regimen (Bortezomib, Lenalidomide, Dexamethasone) is preferred for its efficacy in newly diagnosed multiple myeloma, especially in transplant-eligible patients.
vrd
vcd
multiple myeloma
real-world practice
1

VRD vs VCD Regimen in Real World Clinical Practice
Myelodysplastic Syndromes4m 0s
Selecting Right Patients for Early Initiation in HMAs in Low Risk MDS
Selecting the right patients for early initiation of hypomethylating agents (HMAs) in low-risk MDS involves identifying those with progressive cytopenias, poor prognostic mutations, or high-risk features despite low-risk classification.
hypomethylating agents (hmas)
disease progression
personalised treatment plans
low risk mds
1

Selecting Right Patients for Early Initiation in...
nasopharyngeal carcinoma10m 16s
Toripalimab in Metastatic or Recurrent Nasopharyngeal Carcinoma
Toripalimab, a PD-1 inhibitor, has emerged as a promising treatment for metastatic or locally advanced recurrent NPC. Toripalimab can significantly improve response rates and prolong survival in patients who have progressed on previous therapies
toripalimab
immunotherapy
nasopharyngeal carcinoma
1

Toripalimab in Metastatic or Recurrent...
Myelodysplastic Syndromes6m 1s
Treating AML Patients with Existing Co-Morbidities
Treating Acute Myeloid Leukemia (AML) patients with existing comorbidities is challenging due to the complexities of managing both leukemia and underlying conditions.
acute myeloid leukemia (aml)
comorbidities
tailored treatment
treatment efficacy
1

Treating AML Patients with Existing Co-Morbidities
Prostate Cancer32m 43s
Treatment Intensification for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): The Time is Now
Treatment intensification for metastatic hormone-sensitive prostate cancer (mHSPC) involves combining multiple therapies to improve patient outcomes.
treatment intensification
androgen deprivation therapy (adt)
androgen receptor signaling inhibitor (arsi)
docetaxel
1

Treatment Intensification for Metastatic...
For Pharmacist
For Pharmacist
Brightcove Cards Listing
Webinars
Webinar Cards Listing
MedBytes
MedBytes
Medbytes Cards Listing
Login
To get access to full MedEnrich experience, please Sign in
Don’t have an account? Register Now